Teladoc Health, Inc. provided revenue guidance for the year ending December 31, 2021. For the period, the company expects total revenue to be approximately $2,030 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.18 USD | +0.84% |
|
+14.67% | -52.38% |
07-16 | Teladoc, Brightline to Offer Virtual Pediatric Mental Health Services | MT |
07-09 | Evercore ISI Lowers Price Target on Teladoc to $10 From $14, Maintains In Line Rating | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-52.38% | 1.71B | |
+150.11% | 4.96B | |
-11.42% | 390M | |
+8.04% | 353M | |
-37.99% | 81.27M |
- Stock Market
- Equities
- TDOC Stock
- News Teladoc Health, Inc.
- Teladoc Health, Inc. Provides Revenue Guidance for the Year Ending December 31, 2021